Larry J. Ross

1.9k total citations
32 papers, 1.6k citations indexed

About

Larry J. Ross is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Larry J. Ross has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Infectious Diseases and 6 papers in Virology. Recurrent topics in Larry J. Ross's work include Biochemical and Molecular Research (11 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (6 papers). Larry J. Ross is often cited by papers focused on Biochemical and Molecular Research (11 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (6 papers). Larry J. Ross collaborates with scholars based in United States, United Kingdom and Finland. Larry J. Ross's co-authors include E. Lucile White, David W. Borhani, Robert C. Reynolds, A. Héroux, E. Lucile White, John Delaney, Nessa Hawkins, Xing-Zhong Xia, William J. Boyle and Hailing Hsu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Larry J. Ross

31 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry J. Ross United States 21 737 445 425 249 201 32 1.6k
Seng‐Lai Tan United States 24 800 1.1× 329 0.7× 655 1.5× 688 2.8× 95 0.5× 36 2.4k
Peter A. Wells United States 22 544 0.7× 227 0.5× 160 0.4× 531 2.1× 89 0.4× 49 1.6k
Petra Neddermann Italy 27 1.8k 2.5× 223 0.5× 507 1.2× 820 3.3× 225 1.1× 36 3.2k
Patrick R. Romano United States 21 1.8k 2.5× 176 0.4× 755 1.8× 830 3.3× 208 1.0× 26 3.2k
Gordon Tribbick Australia 16 1.0k 1.4× 134 0.3× 389 0.9× 313 1.3× 118 0.6× 30 1.9k
I K Dev United States 24 975 1.3× 198 0.4× 168 0.4× 156 0.6× 248 1.2× 35 1.6k
Joseph P. Davide United States 22 1.3k 1.7× 392 0.9× 265 0.6× 205 0.8× 115 0.6× 37 2.1k
Himadri Samanta United States 19 676 0.9× 298 0.7× 393 0.9× 116 0.5× 64 0.3× 35 1.2k
William Markland United States 20 1.1k 1.4× 288 0.6× 120 0.3× 441 1.8× 137 0.7× 31 2.0k
Kurt Morgenstern United States 13 849 1.2× 293 0.7× 109 0.3× 515 2.1× 112 0.6× 19 1.8k

Countries citing papers authored by Larry J. Ross

Since Specialization
Citations

This map shows the geographic impact of Larry J. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry J. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry J. Ross more than expected).

Fields of papers citing papers by Larry J. Ross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry J. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry J. Ross. The network helps show where Larry J. Ross may publish in the future.

Co-authorship network of co-authors of Larry J. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Larry J. Ross. A scholar is included among the top collaborators of Larry J. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry J. Ross. Larry J. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mathew, Bini, Judith V. Hobrath, Larry J. Ross, et al.. (2016). Screening and Development of New Inhibitors of FtsZ from M. Tuberculosis. PLoS ONE. 11(10). e0164100–e0164100. 23 indexed citations
2.
Zhang, Wei, Ling Zhai, Yimin Wang, et al.. (2016). Discovery of a novel inhibitor of kinesin-like protein KIFC1. Biochemical Journal. 473(8). 1027–1035. 37 indexed citations
3.
Owusu, Benjamin Y., Namita Bansal, Larry J. Ross, et al.. (2015). Design and Synthesis of Nonpeptide Inhibitors of Hepatocyte Growth Factor Activation. ACS Medicinal Chemistry Letters. 7(2). 177–181. 18 indexed citations
4.
Mathew, Bini, Larry J. Ross, & Robert C. Reynolds. (2013). A novel quinoline derivative that inhibits mycobacterial FtsZ. Tuberculosis. 93(4). 398–400. 25 indexed citations
5.
Mathew, Bini, Shefali Srivastava, Larry J. Ross, et al.. (2011). Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors. Bioorganic & Medicinal Chemistry. 19(23). 7120–7128. 40 indexed citations
6.
Ross, Larry J.. (2010). Driving Without Destination. The Chesterton Review. 36(3). 308–309. 1 indexed citations
7.
Mukherjee, Prasenjit, Prashant Desai, Larry J. Ross, E. Lucile White, & Mitchell A. Avery. (2008). Structure-based virtual screening against SARS-3CLpro to identify novel non-peptidic hits. Bioorganic & Medicinal Chemistry. 16(7). 4138–4149. 38 indexed citations
8.
White, E. Lucile, Larry J. Ross, Rachel Gill, et al.. (2006). A Novel Inhibitor of Mycobacterium tuberculosis Pantothenate Synthetase. SLAS DISCOVERY. 12(1). 100–105. 58 indexed citations
9.
White, E. Lucile, et al.. (2004). Cloning, expression, and characterization ofMycobacterium tuberculosisdihydrofolate reductase. FEMS Microbiology Letters. 232(1). 101–105. 36 indexed citations
10.
Leung, Adelaine Kwun-Wai, E. Lucile White, Larry J. Ross, et al.. (2004). Structure of Mycobacterium tuberculosis FtsZ Reveals Unexpected, G Protein-like Conformational Switches. Journal of Molecular Biology. 342(3). 953–970. 105 indexed citations
11.
Klon, Anthony E., A. Héroux, Larry J. Ross, et al.. (2002). Atomic Structures of Human Dihydrofolate Reductase Complexed with NADPH and Two Lipophilic Antifolates at 1.09Å and 1.05Å Resolution. Journal of Molecular Biology. 320(3). 677–693. 61 indexed citations
12.
Leung, Adelaine Kwun-Wai, E. Lucile White, Larry J. Ross, & David W. Borhani. (2000). Crystallization of theMycobacterium tuberculosiscell-division protein FtsZ. Acta Crystallographica Section D Biological Crystallography. 56(12). 1634–1637. 11 indexed citations
13.
Héroux, A., et al.. (2000). Substrate Deformation in a Hypoxanthine-Guanine Phosphoribosyltransferase Ternary Complex. Structure. 8(12). 1309–1318. 64 indexed citations
14.
White, E. Lucile, et al.. (2000). The Two Toxoplasma gondii Hypoxanthine-Guanine Phosphoribosyltransferase Isozymes Form Heterotetramers. Journal of Biological Chemistry. 275(25). 19218–19223. 6 indexed citations
15.
White, E. Lucile, Wan‐Ru Chao, Larry J. Ross, et al.. (1999). Michellamine Alkaloids Inhibit Protein Kinase C. Archives of Biochemistry and Biophysics. 365(1). 25–30. 17 indexed citations
16.
Héroux, A., E. Lucile White, Larry J. Ross, & David W. Borhani. (1999). Crystal Structures of the Toxoplasma gondii Hypoxanthine-Guanine Phosphoribosyltransferase−GMP and −IMP Complexes:  Comparison of Purine Binding Interactions with the XMP Complex,. Biochemistry. 38(44). 14485–14494. 55 indexed citations
17.
Ross, Larry J. & Linda A. Guarino. (1997). Cycloheximide Inhibition of Delayed Early Gene Expression in Baculovirus-Infected Cells. Virology. 232(1). 105–113. 41 indexed citations
18.
White, E. Lucile, William B. Parker, Larry J. Ross, & William M. Shannon. (1993). Lack of synergy in the inhibition of HIV-1 reverse transcriptase by combinations of the 5′-triphosphates of various anti-HIV nucleoside analogs. Antiviral Research. 22(4). 295–308. 24 indexed citations
19.
Buckheit, Robert W., Melinda G. Hollingshead, E. Lucile White, et al.. (1993). Thiazolobenzimidazole: Biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor. Antiviral Research. 21(3). 247–265. 86 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seng‐Lai Tan Breakdown of academic impact, for papers by Peter A. Wells Breakdown of academic impact, for papers by Petra Neddermann Breakdown of academic impact, for papers by Patrick R. Romano Breakdown of academic impact, for papers by Gordon Tribbick Breakdown of academic impact, for papers by I K Dev Breakdown of academic impact, for papers by Joseph P. Davide Breakdown of academic impact, for papers by Himadri Samanta Breakdown of academic impact, for papers by William Markland Breakdown of academic impact, for papers by Kurt Morgenstern
Rankless by CCL
2026